+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Hansen's disease and the digestive system: clinical symptoms and gastric secretory profile at baseline conditions and following maximum stimulation with pentagastrin



Hansen's disease and the digestive system: clinical symptoms and gastric secretory profile at baseline conditions and following maximum stimulation with pentagastrin



Acta Leprologica 11(3): 99-104



The incidence of digestive symptoms in 100 patients with Hansen's disease was evaluated in this study, following a standardized questionnaire. A correlation between the frequency of symptoms, the form of the disease, and the length of treatment was investigated. Digestive symptoms were found in 31 patients (31%). No statistically significant difference was found between the presence of symptoms and the length of the disease or between the multibacillary and the paucibacillary form of the disease. However, a positive correlation between digestive symptoms and Hansen's disease was found in the multibacillary form of the disease only for patients treated for more than 12 months. Baseline and pentagastrin-stimulated gastric acid secretion was studied in 30 Hansen's disease patients and in 10 controls. A Iower basal acid output was observed in patients with Hansen's disease, but no statistical difference was found. Pentagastrin-stimulated gastric acid secretion was statistically different in Hansen's disease patients, as compared to controls. A Iower pentagastrin-stimulated acid secretion was found in Hansen's disease patients under treatment, as compared to untreated patients, but the difference was not statistically significant.

(PDF emailed within 1 workday: $29.90)

Accession: 046211817

Download citation: RISBibTeXText

PMID: 10544722


Related references

Gastric secretion following maximum stimulation with histamine or pentagastrin in 150 patients with digestive tract diseases or anemia. Wiadomosci Lekarskie 28(7): 557-562, 1975

Clinical use of the simultaneous measurement of gastric emptying and the maximum gastric acid secretion stimulated with pentagastrin or histamine. Revista Espanola de Las Enfermedades del Aparato Digestivo 47(2): 161-168, 1976

Comparison of the effect of gastric secretion stimulation with histamine and pentagastrin in digestive organ diseases. Klinicheskaia Khirurgiia: 66-67, 1983

Gastric secretory response to cholinergic stimulation in rats chronically pretreated with pentagastrin or histamine in depot form. Digestion 14(4): 368-371, 1976

Secretory response of gastric mucosa to maximal stimulation with pentagastrin in patients with affections of the stomach and the duodenum in comparison to controls. Medizinische Klinik 69(27): 1193-1201, 1974

Study of enzyme secretory activity of the small intestine under clinical conditions in some diseases of the digestive system. Laboratornoe Delo 1: 8-10, 1969

Stimulation of gastric-acid secretion by histamine, pentagastrin, and pentagastrin-propantheline after vagotomy in man. Lancet 2(7506): 67-69, 1967

Hemostatic properties of gastric juice under basal conditions and after stimulation with pentagastrin or secretin-pancreozymin. Leber, Magen, Darm 10(1): 54-57, 1980

The clinical application of gastric analysis with stimulation of pentagastrin. Hua Xi Yi Ke Da Xue Xue Bao 17(3): 241-244, 1986

Fade and tachyphylaxis of gastric acid secretory response to pentagastrin in rat isolated gastric mucosa. British Journal of Pharmacology 95(4): 1047-1056, 1988

Pathogenetic and clinical significance of pentagastrin stimulation of gastric secretion in the active phase of peptic ulcer. Vutreshni Bolesti 18(1): 83-88, 1979

Digestive system manifestations in Steinert's disease. Analysis of 19 cases of which 10 with digestive symptoms. Acta Gastro-Enterologica Belgica 53(1): 3-15, 1990

The gastric acid secretion under basal conditions and after maximal stimulation in normal subjects and in different pathological conditions of the upper digestive tract 215 cases. Acta Medica Romana 18(3): 316-323, 1980

Effect of carbenoxolone on gastric prostaglandin E2 levels in patients with peptic ulcer disease following vagal and pentagastrin stimulation. European Journal of Clinical Investigation 13(4): 351-356, 1983